News analysis for professionals in the cannabis industry

Coca-Cola heir launches bank and cryptocurrency just for hemp trade

Written by CannIntelligence | 21st August 2019

A Greek billionaire claims to have launched the world’s first bank specifically focused on supporting the hemp and legal cannabis markets ...

Italians sell CBD flowers as ‘animal feed’ to avoid confused enforcement

Written by CannIntelligence | 21st August 2019

Some Italian companies have begun to register CBD hemp flower products as animal feed in an attempt to avoid regulatory confusion and uneven enforcement in the country ...

Unilever still on target to deliver hemp oil deodorant in US stores

Written by CannIntelligence | 21st August 2019

Unilever, one of the world's largest consumer goods companies, is still planning to launch its own CBD-infused deodorant under its Schmidt’s Naturals brand ...

CannTrust’s future cast in doubt after renewed troubles with Health Canada

Written by CannIntelligence | 20th August 2019

The future of one of Canada's largest cannabis companies is hanging in the balance after a whistleblower and an unannounced inspection by Health Canada triggered a series of problems for CannTrust ...

Kannaway hopes to use Bulgarian licence as a doorway into EU markets

Written by Freddie Dawson | 20th August 2019

CBD supplier Kannaway says it has been granted licences confirming compliance with the law and permitting free sale of a product in an EU member state – Bulgaria – as well as in Russia ...

Mexico holds open talks in move towards legalisation of cannabis

Written by CannIntelligence | 19th August 2019

The precise role Mexico’s government should play in a future cannabis industry was among the major issues discussed at a recent three-day event hosted by the country’s Senate ...

CBD-Intel regulatory news in brief

Written by CannIntelligence | 19th August 2019

CBD-Intel’s regular round-up of regulatory news features items from the US, Mexico, Germany, Italy, Spain, Thailand, Trinidad and Tobago, and the self-governing UK dependency of Jersey ...

CBD-Intel business news in brief, 10th-16th August 2019

Written by CannIntelligence | 19th August 2019

Kylie Jenner gets happy – CBD-Intel’s weekly round-up of business snippets includes items from the US, Canada, Ireland and Australia ...

New clinical trial investigates CBD-infused oral health products

Written by Lorraine Mullaney | 19th August 2019

A new clinical trial is investigating the efficacy of CBD-infused mouthwashes and toothpaste when used to treat gum disease. The randomised controlled clinical trial is a collaboration between Australian medicinal cannabis business Impression Healthcare and...

UK’s draft medical guidelines give little support to CBD or cannabis

Written by CannIntelligence | 16th August 2019

The panel responsible for recommending which drugs England’s National Health Service (NHS) should prescribe may recommend against the organisation using cannabis-based medical...

Holland & Barrett tests the water with health claims for new CBD range

Written by CannIntelligence | 16th August 2019

The UK's largest high street health food retailer is increasing the number of CBD products it sells with a new range – and with it testing the rules on health claims ...

US Gallup poll reveals CBD usage and awareness parallels

Written by Freddie Dawson | 15th August 2019

A new Gallup poll has found that usage of CBD products among American consumer almost exactly mirrors awareness. The poll found that around 14% of those surveyed used CBD while 50% did not, though they...

First Jersey hemp licence issued – ‘a significant opportunity’ for island

Written by Freddie Dawson | 14th August 2019

Hemp can now be grown on the Channel Island of Jersey following the issuance of the first licence to harvest, process and store hemp flower in preparation for CBD...

CBD vaping expected to continue growth, say stakeholders

Written by CannIntelligence | 13th August 2019

CBD vaping stakeholders in Europe expect to see the category continue to grow – fuelled by unclear regulations over CBD as a food ingredient combined with a low barrier to entry ...

CBD-Intel business news in brief, 3rd-9th August 2019

Written by CannIntelligence | 13th August 2019

The latest news and developments in the CBD industry worldwide rounded up in CBD-Intel's weekly News In...

CBD-Intel regulatory news in brief

Written by CannIntelligence | 12th August 2019

CBD-Intel’s regular round-up of regulatory news features items from Germany, Switzerland, Belgium, the UK, and the...

A hole in one – will sports and CBD continue to entwine?

Written by Lorraine Mullaney | 8th August 2019

The sports world is becoming increasingly enamoured with CBD. US professional golfers have become the latest sporting personalities to endorse CBD products, including 2009 US Open winner Lucas Glover. Will CBD continue to wind its way...

CBD-Intel bonus midweek regulatory alerts, 8th August 2019

Written by CannIntelligence | 8th August 2019

CBD-Intel’s regular round-up of regulatory news features items from Portugal, the UK, Germany, Italy, Denmark, North America, Mexico, Colombia and...

The future of CBD-infused beverages is bright

Written by CannIntelligence | 7th August 2019

Interest and investment in CBD beverages continues to grow despite some criticism of cannabis drinks in general; so far, the industry has struggled to get oil-based cannabinoids into water-based beverages without issues. But all of...

Enterprise Ireland halts funding while it continues to review CBD issues

Written by CannIntelligence | 5th August 2019

The organisation which helps new business in the Republic of Ireland has performed a U-turn on its previous commitment to CBD companies ...

CBD-Intel business news in brief, 29th July-2nd August 2019

Written by CannIntelligence | 5th August 2019

US food and pharmacy chain Kroger has increased its range of CBD products with deals to distribute CV Sciences, Veritas Farms and Charlotte’s Web products in 1350 stores across 22 states ...

CBD-Intel regulatory news in brief

Written by CannIntelligence | 5th August 2019

CBD-Intel’s regular round-up of regulatory news features items from Germany, Italy, France, the Netherlands, Spain, Luxembourg, Canada, the US and South Africa ...

UK hemp farmer claims Home Office delays caused crop destruction

Written by CannIntelligence | 2nd August 2019

A UK hemp farming co-operative has told CBD-Intel of its plans to launch a campaign to raise support for legislative changes to support the UK CBD industry ...

MHRA enforces CBD rules with British store

Written by CannIntelligence | 1st August 2019

A British shop specialising in hemp-related products says it has been told to remove some information from its website by the organisation responsible for regulating medicinal health...

Epidyolex takes huge step toward EU licensing

Written by CannIntelligence | 31st July 2019

A European review committee has recommended that British company GW Pharmaceuticals’ Epidyolex (known as Epidiolex in the US) be licensed as a medicine in the European...

US urgently needs hemp regulations, Senate is told

Written by CannIntelligence | 30th July 2019

Rising demand for hemp products could soon make it an important cash crop for America but both industry and regulators must change to meet evolving demands and...

CannTrust leaders axed, confusion in Italy: regulatory news in brief

Written by CannIntelligence | 29th July 2019

CBD-Intel’s regular round-up of regulatory news features items from Canada, New York, Texas, Nevada, Washington State, Italy and Portugal ...

CBD-Intel business news in brief, 22nd-26th July 2019

Written by CannIntelligence | 29th July 2019

Can CBD affect fertility in mice and men? CBD-Intel brings you this and other stories in our regular round-up of business snippets ...

No Euphoria here – Ireland recalls Dutch oil from sale over THC content

Written by CannIntelligence | 26th July 2019

A batch of CBD oil has been removed from sale by authorities in the Republic of Ireland after it was found to contain THC ...

Curaleaf in hot water with FDA over ‘improper health claims’

Written by CannIntelligence | 25th July 2019

The US FDA has issued a warning to Curaleaf, which it says is selling CBD products with improper claims to treat diseases like cancer, withdrawal from opioids, pain, and anxiety ...

Senate hearing raises hope of SAFE banking for US CBD industry

Written by CannIntelligence | 25th July 2019

Many US senators seem ready to pass a law allowing financial institutions to work with CBD businesses. That’s if a hearing on the SAFE Banking Act is any indication ...

Poland’s bizarre rules mean CBD oil is taxed as food but labelled non-edible

Written by CannIntelligence | 25th July 2019

The Polish CBD sector is beset by confusing regulation and uneven enforcement – but it does benefit from a reduced rate of VAT, below even that of prescription medical cannabis ...

FDA gathers in opposing strong views and cannabis-related anecdotes

Written by CannIntelligence | 25th July 2019

The US Food and Drug Administration (FDA)’s request for comments on regulating cannabis-related products drew 4492 responses covering a dizzying array of views ...

CBD-Intel regulatory news in brief

Written by CannIntelligence | 24th July 2019

CBD-Intel brings you regulatory updates and snippets from the US, UK, Italy, Germany and Belgium ...

Spanish researchers find half of CBD oil labels fail the accuracy test

Written by Lydia Thompson | 24th July 2019

Some CBD oils are not “exactly what they say on the tin”, the Spanish Medicinal Cannabis Observatory (Observatorio Español de Cannabis Medicinal) has found ...

Can CBD products really be food and drink to a hungry market?

Written by CannIntelligence | 24th July 2019

Sales of water infused with CBD may be held back by doubts over whether the product is effective and also by regulation, recent reporting by CBD-Intel suggests ...

CBD is going to the dogs (and horses and cats) to relieve their stress too

Written by CannIntelligence | 23rd July 2019

In this dog-eat-dog world it’s not only humans who have to deal with stress – our four-legged friends also suffer from anxiety. But CBD can help, say manufacturers ...

Survey reveals evidence of growth potential in French CBD market

Written by CannIntelligence | 23rd July 2019

Regular users of CBD in France are increasing their consumption, which means the French market offers great potential for growth. That’s one of the findings from research carried out by CBD-Intel ...

Is Serbia set to place ‘psychoactive’ CBD on the controlled list?

Written by Marija Obradovic | 23rd July 2019

A tough regulatory regime in Serbia may soon become even tougher as the Commission for Psychoactive Controlled Substances believes CBD should be a scheduled substance ...

Health Canada steps up vigilance, with clamps on Agrima and CannTrust

Written by CannIntelligence | 22nd July 2019

Health Canada has revoked the licence of producer Agrima Botanicals and put a hold on product grown by CannTrust ...

CBD-Intel regulatory news in brief

Written by CannIntelligence | 22nd July 2019

CBD-Intel’s regular round-up of regulatory snippets features news from the US, Europe and China ...

CBD-Intel business news in brief, 15th-19th July 2019

Written by CannIntelligence | 22nd July 2019

Christian Books or hemp extract? CBD-Intel brings you a pot-pourri of CBD-related news snippets from around the business world ...

US senators push for law change to ease research into CBD and cannabis

Written by CannIntelligence | 18th July 2019

While the US FDA looks at paths for providing CBD research and routes to market, Congress may have a further opportunity to encourage legal developments in that direction ...

UK high street giant puts CBD at the heart of its flagship London store

Written by CannIntelligence | 18th July 2019

The flagship London store of the UK’s largest pharmacy chain will feature CBD products heavily in its “largest ever” wellness section following redevelopment ...

Italy’s Supreme Court explanation leaves ‘psychotropic effect’ unclear

Written by CannIntelligence | 18th July 2019

Italy’s Supreme Court has published the reasoning behind its ruling that cannabis products are illegal except for those without psychotropic effects – without adding any clarity ...

CBD: a fragmented market in an uncertain regulatory landscape

Written by CannIntelligence | 17th July 2019

From hummus to suppositories, the UK CBD market is highly fragmented, with over 700 brands available, as CBD-Intel managing director Tim Phillips explains in this presentation given at the Europe CBD Expo in London ...

Congressional pressure builds in favour of progress on CBD

Written by CannIntelligence | 17th July 2019

Attention in Washington is increasingly focused on CBD, with the US Congress striving to address regulation and the FDA promising policy action soon ...

It’s business as unusual over CBD in topsy-turvy Washington circles

Written by CannIntelligence | 15th July 2019

CBD has turned Washington upside down, with a legal expert at the conservative Heritage Foundation testifying to Congress on behalf of federalism over states’ rights and free enterprise ...

CBD-Intel regulatory news in brief

Written by CannIntelligence | 15th July 2019

CBD-Intel brings you regulatory updates from Italy, France, Turkey, New Zealand, El Salvador, the US states of Delaware and South Dakota and the island territory of Guam ...

CBD-Intel business news in brief, 8th-12th July 2019

Written by CannIntelligence | 15th July 2019

CBD-Intel brings you up-to-date with the latest developments in the fast-moving world of CBD business deals ...

LATEST ALERTS

Written by CannIntelligence | 21st August 2019

Written by CannIntelligence | 21st August 2019

Written by CannIntelligence | 21st August 2019

Written by CannIntelligence | 20th August 2019

Written by Freddie Dawson | 20th August 2019

Written by CannIntelligence | 19th August 2019

Written by CannIntelligence | 19th August 2019

Written by CannIntelligence | 19th August 2019

Written by Lorraine Mullaney | 19th August 2019

Written by CannIntelligence | 16th August 2019

Written by CannIntelligence | 16th August 2019

Written by Freddie Dawson | 15th August 2019

Written by Freddie Dawson | 14th August 2019

Written by CannIntelligence | 13th August 2019

Written by CannIntelligence | 13th August 2019

Written by CannIntelligence | 12th August 2019

Written by Lorraine Mullaney | 8th August 2019

Written by CannIntelligence | 8th August 2019

Written by CannIntelligence | 7th August 2019

Written by CannIntelligence | 5th August 2019

Written by CannIntelligence | 5th August 2019

Written by CannIntelligence | 5th August 2019

Written by CannIntelligence | 2nd August 2019

Written by CannIntelligence | 1st August 2019

Written by CannIntelligence | 31st July 2019

Written by CannIntelligence | 30th July 2019

Written by CannIntelligence | 29th July 2019

Written by CannIntelligence | 29th July 2019

Written by CannIntelligence | 26th July 2019

Written by CannIntelligence | 25th July 2019

Written by CannIntelligence | 25th July 2019

Written by CannIntelligence | 25th July 2019

Written by CannIntelligence | 25th July 2019

Written by CannIntelligence | 24th July 2019

Written by Lydia Thompson | 24th July 2019

Written by CannIntelligence | 24th July 2019

Written by CannIntelligence | 23rd July 2019

Written by CannIntelligence | 23rd July 2019

Written by Marija Obradovic | 23rd July 2019

Written by CannIntelligence | 22nd July 2019

Written by CannIntelligence | 22nd July 2019

Written by CannIntelligence | 22nd July 2019

Written by CannIntelligence | 18th July 2019

Written by CannIntelligence | 18th July 2019

Written by CannIntelligence | 18th July 2019

Written by CannIntelligence | 17th July 2019

Written by CannIntelligence | 17th July 2019

Written by CannIntelligence | 15th July 2019

Written by CannIntelligence | 15th July 2019

Written by CannIntelligence | 15th July 2019

Sign up to our newsletter

Start your FREE trial